Ad blocking detected

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.


Captor Capital Corp. (C:CPTR)

Business Focus: Alternative Medicine

Get the company report for the most recent outlook updated daily

Insider Chart - Past 6 Months

Insider Filings

Latest 10 SEDI filings for CPTR within the last 6 months
See all filings within the past 6 months

Company News

Aug 29, 2022 18:57 ET
Captor Capital Releases Unaudited Condensed Interim Consolidated Financial Statements for Quarter Ended June 30, 2022
Captor Capital Corp. (CSE: CPTR; FRANKFURT: NMVA; STUGGART: NMVA), (“Captor” or the “Company”), is pleased to announce today the release of its Unaudited Condensed Interim Consolidated Financial Statements and MD&A for the three months ended June...
Read full article
Aug 02, 2022 08:06 ET
Captor Capital Reports $32,737,461 in Revenues and 132 percent Increase in Gross Profits in Annual Audited Financial Statements for the Year Ended March 31, 2022
Captor Capital Corp. (CSE: CPTR; FRANKFURT: NMVA; STUTTGART: NMVA), ("Captor" or the "Company"), is pleased to announce today the release of its Audited Annual Financial Statements and MD&A for the year ended March 31, 2022. For the twelve months...
Read full article
See more news stories

Valuation Ratios

Price to Sales - TTM
Price to Book - most recent quarter
Price to Cash Flow per share - TTM
Price to Free Cash Flow per share - TTM
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Sep 15, 20225620
Aug 31, 20225620
Aug 15, 20225620
See Short Report

Business Summary

Sector:  Healthcare Industry:  Pharmaceuticals

Captor Capital Corp is a Canada-based vertically integrated cannabis company. The Company cultivates, manufactures and distributes medical marijuana-based products to consumers through its brands and dispensary retail stores. The Company provides cannabis products, as well as other cannabis-based goods. The Company's California joint venture portfolio consists two CHAI Cannabis Co. branded dispensaries, four One Plant branded dispensaries and three additional California cannabis retail licenses for stores under construction. CHAI Santa Cruz is a medical and cannabis dispensary in Santa Cruz County.

See business summary



Search (past week) for $CPTR.CA

  • No tweets found